Cargando…
Assessing cognitive impairment in SLE: examining relationships between resting glucose metabolism and anti-NMDAR antibodies with navigational performance
OBJECTIVE: Resting Fluorine-18 fluorodeoxyglucose positron emission tomography (FDG-PET) brain imaging and neuropsychological testing were used to investigate the usefulness of a spatial navigation task (SNT) as a performance benchmark for cognitive impairment related to anti-N-methyl D-aspartate (a...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6667777/ https://www.ncbi.nlm.nih.gov/pubmed/31413849 http://dx.doi.org/10.1136/lupus-2019-000327 |
_version_ | 1783440096576405504 |
---|---|
author | Ploran, Elisabeth Tang, Chris Mackay, Meggan Small, Michael Anderson, Erik Storbeck, Justin Bascetta, Brittany Kang, Simran Aranow, Cynthia Sartori, Carl Watson, Philip Volpe, Bruce Diamond, Betty Eidelberg, David |
author_facet | Ploran, Elisabeth Tang, Chris Mackay, Meggan Small, Michael Anderson, Erik Storbeck, Justin Bascetta, Brittany Kang, Simran Aranow, Cynthia Sartori, Carl Watson, Philip Volpe, Bruce Diamond, Betty Eidelberg, David |
author_sort | Ploran, Elisabeth |
collection | PubMed |
description | OBJECTIVE: Resting Fluorine-18 fluorodeoxyglucose positron emission tomography (FDG-PET) brain imaging and neuropsychological testing were used to investigate the usefulness of a spatial navigation task (SNT) as a performance benchmark for cognitive impairment related to anti-N-methyl D-aspartate (anti-NMDA) receptor antibodies (DNRAb) in SLE. METHODS: Neuropsychological assessments, including a desktop 3-D virtual SNT, were performed on 19 SLE participants and 9 healthy control (HC) subjects. SLE participants had stable disease activity and medication doses and no history of neuropsychiatric illness or current use of mind-altering medications. Resting FDG-PET scans were obtained on all SLE participants and compared with a historical set from 25 age-matched and sex-matched HCs. Serum DNRAb titres were measured by ELISA. RESULTS: 11/19 (58%) of SLE participants failed to complete the SNT (SNT−) compared with 2/9 (22%) of HCs. Compared with 7/9 (78%) in HCs, only 2/9 (22%; p=0.037) of SLE participants with high serum DNRAb titres completed the SNT, in contrast to 6/10 (60%; p=0.810) in SLE participants with low DNRAb titres. Voxel-wise comparison of FDG-PET scans between the 8 SLE participants successfully completing the SNT task (SNT+) and the 11 SNT− SLE participants revealed increased metabolism in the SNT+ participants (p<0.001) in the left anterior putamen/caudate, right anterior putamen, left prefrontal cortex (BA 9), right prefrontal cortex (BA 9/10) and left lateral and medial frontal cortex (BA 8). Compared with HCs, the SNT+ group demonstrated increased metabolism in all regions (p<0.02) except for the right prefrontal cortex (BA 9), whereas the SNT− group demonstrated either significantly decreased or similar metabolism in these seven regions. CONCLUSIONS: SNT performance is associated with serum DNRAb titres and resting glucose metabolism in the anterior putamen/caudate and frontal cortex, suggesting compensatory neural recruitment in SNT-associated regions is necessary for successful completion of the task. The SNT therefore has potential for use as a marker for SLE-mediated cognitive impairment. |
format | Online Article Text |
id | pubmed-6667777 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-66677772019-08-14 Assessing cognitive impairment in SLE: examining relationships between resting glucose metabolism and anti-NMDAR antibodies with navigational performance Ploran, Elisabeth Tang, Chris Mackay, Meggan Small, Michael Anderson, Erik Storbeck, Justin Bascetta, Brittany Kang, Simran Aranow, Cynthia Sartori, Carl Watson, Philip Volpe, Bruce Diamond, Betty Eidelberg, David Lupus Sci Med Epidemiology and Outcomes OBJECTIVE: Resting Fluorine-18 fluorodeoxyglucose positron emission tomography (FDG-PET) brain imaging and neuropsychological testing were used to investigate the usefulness of a spatial navigation task (SNT) as a performance benchmark for cognitive impairment related to anti-N-methyl D-aspartate (anti-NMDA) receptor antibodies (DNRAb) in SLE. METHODS: Neuropsychological assessments, including a desktop 3-D virtual SNT, were performed on 19 SLE participants and 9 healthy control (HC) subjects. SLE participants had stable disease activity and medication doses and no history of neuropsychiatric illness or current use of mind-altering medications. Resting FDG-PET scans were obtained on all SLE participants and compared with a historical set from 25 age-matched and sex-matched HCs. Serum DNRAb titres were measured by ELISA. RESULTS: 11/19 (58%) of SLE participants failed to complete the SNT (SNT−) compared with 2/9 (22%) of HCs. Compared with 7/9 (78%) in HCs, only 2/9 (22%; p=0.037) of SLE participants with high serum DNRAb titres completed the SNT, in contrast to 6/10 (60%; p=0.810) in SLE participants with low DNRAb titres. Voxel-wise comparison of FDG-PET scans between the 8 SLE participants successfully completing the SNT task (SNT+) and the 11 SNT− SLE participants revealed increased metabolism in the SNT+ participants (p<0.001) in the left anterior putamen/caudate, right anterior putamen, left prefrontal cortex (BA 9), right prefrontal cortex (BA 9/10) and left lateral and medial frontal cortex (BA 8). Compared with HCs, the SNT+ group demonstrated increased metabolism in all regions (p<0.02) except for the right prefrontal cortex (BA 9), whereas the SNT− group demonstrated either significantly decreased or similar metabolism in these seven regions. CONCLUSIONS: SNT performance is associated with serum DNRAb titres and resting glucose metabolism in the anterior putamen/caudate and frontal cortex, suggesting compensatory neural recruitment in SNT-associated regions is necessary for successful completion of the task. The SNT therefore has potential for use as a marker for SLE-mediated cognitive impairment. BMJ Publishing Group 2019-07-11 /pmc/articles/PMC6667777/ /pubmed/31413849 http://dx.doi.org/10.1136/lupus-2019-000327 Text en © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/. |
spellingShingle | Epidemiology and Outcomes Ploran, Elisabeth Tang, Chris Mackay, Meggan Small, Michael Anderson, Erik Storbeck, Justin Bascetta, Brittany Kang, Simran Aranow, Cynthia Sartori, Carl Watson, Philip Volpe, Bruce Diamond, Betty Eidelberg, David Assessing cognitive impairment in SLE: examining relationships between resting glucose metabolism and anti-NMDAR antibodies with navigational performance |
title | Assessing cognitive impairment in SLE: examining relationships between resting glucose metabolism and anti-NMDAR antibodies with navigational performance |
title_full | Assessing cognitive impairment in SLE: examining relationships between resting glucose metabolism and anti-NMDAR antibodies with navigational performance |
title_fullStr | Assessing cognitive impairment in SLE: examining relationships between resting glucose metabolism and anti-NMDAR antibodies with navigational performance |
title_full_unstemmed | Assessing cognitive impairment in SLE: examining relationships between resting glucose metabolism and anti-NMDAR antibodies with navigational performance |
title_short | Assessing cognitive impairment in SLE: examining relationships between resting glucose metabolism and anti-NMDAR antibodies with navigational performance |
title_sort | assessing cognitive impairment in sle: examining relationships between resting glucose metabolism and anti-nmdar antibodies with navigational performance |
topic | Epidemiology and Outcomes |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6667777/ https://www.ncbi.nlm.nih.gov/pubmed/31413849 http://dx.doi.org/10.1136/lupus-2019-000327 |
work_keys_str_mv | AT ploranelisabeth assessingcognitiveimpairmentinsleexaminingrelationshipsbetweenrestingglucosemetabolismandantinmdarantibodieswithnavigationalperformance AT tangchris assessingcognitiveimpairmentinsleexaminingrelationshipsbetweenrestingglucosemetabolismandantinmdarantibodieswithnavigationalperformance AT mackaymeggan assessingcognitiveimpairmentinsleexaminingrelationshipsbetweenrestingglucosemetabolismandantinmdarantibodieswithnavigationalperformance AT smallmichael assessingcognitiveimpairmentinsleexaminingrelationshipsbetweenrestingglucosemetabolismandantinmdarantibodieswithnavigationalperformance AT andersonerik assessingcognitiveimpairmentinsleexaminingrelationshipsbetweenrestingglucosemetabolismandantinmdarantibodieswithnavigationalperformance AT storbeckjustin assessingcognitiveimpairmentinsleexaminingrelationshipsbetweenrestingglucosemetabolismandantinmdarantibodieswithnavigationalperformance AT bascettabrittany assessingcognitiveimpairmentinsleexaminingrelationshipsbetweenrestingglucosemetabolismandantinmdarantibodieswithnavigationalperformance AT kangsimran assessingcognitiveimpairmentinsleexaminingrelationshipsbetweenrestingglucosemetabolismandantinmdarantibodieswithnavigationalperformance AT aranowcynthia assessingcognitiveimpairmentinsleexaminingrelationshipsbetweenrestingglucosemetabolismandantinmdarantibodieswithnavigationalperformance AT sartoricarl assessingcognitiveimpairmentinsleexaminingrelationshipsbetweenrestingglucosemetabolismandantinmdarantibodieswithnavigationalperformance AT watsonphilip assessingcognitiveimpairmentinsleexaminingrelationshipsbetweenrestingglucosemetabolismandantinmdarantibodieswithnavigationalperformance AT volpebruce assessingcognitiveimpairmentinsleexaminingrelationshipsbetweenrestingglucosemetabolismandantinmdarantibodieswithnavigationalperformance AT diamondbetty assessingcognitiveimpairmentinsleexaminingrelationshipsbetweenrestingglucosemetabolismandantinmdarantibodieswithnavigationalperformance AT eidelbergdavid assessingcognitiveimpairmentinsleexaminingrelationshipsbetweenrestingglucosemetabolismandantinmdarantibodieswithnavigationalperformance |